Innovation1 Biotech Inc. (OTCMKTS:IVBT) Biotech Files Patent for Novel Combination Therapy Targeting Addiction

August 19, 2022

Innovation1 Biotech Inc. (OTCMKTS:IVBT), announced on august 18, 2022, about filing a provisional patent application with the United States Patent and Trademark Office (USPTO) covering its novel and proprietary combination therapy targeting the addiction center in the human brain. Trading Data On Thursday, IVBT stock soared 27.52% to $0.3750 with more than 325 shares, compared to its average volume of 1K shares. The stock moved within a range of $0.3749…